7.24 USD
↗ 0.55 (8.22%)AT CLOSE (11:59 AM EDT)
enGene Holdings Inc. Common Stock
ENGNNASDAQ • USD
7.25
↗ 0.06 (0.83%)
POST MARKET (AS OF 05:19 PM EDT)
Post Market
AS OF 05:19 PM EDT
7.25
↗ 0.06 (0.83%)
Market: OPEN
Open?$6.69
High?$7.30
Low?$6.69
Prev. Close?$6.69
Volume?218.2K
Avg. Volume?462.8K
VWAP?$7.04
Rel. Volume?0.47x
Bid / Ask
Bid?$6.03 × 100
Ask?$8.46 × 100
Spread?$2.43
Midpoint?$7.25
Valuation & Ratios
Market Cap?448.2M
Shares Out?67.0M
Float?37.7M
Float %?58.4%
P/E Ratio?N/A
P/B Ratio?1.59
EPS?-$1.83
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.75Strong
Quick Ratio?11.75Strong
Cash Ratio?1.49Strong
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.59CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-43.5%WEAK▾
ROA?-36.3%WEAK▾
Cash Flow & Enterprise
FCF?$-103785000
Enterprise Value?$436.5M
Related Companies
Loading...
News
Profile
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Employees
82
Market Cap
448.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-11-01
Address
4868 RUE LEVY, SUITE 220
SAINT-LAURENT, A8 H4R 2P1
Phone: (514) 332-4888
SAINT-LAURENT, A8 H4R 2P1
Phone: (514) 332-4888